Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11760797 Anti-interleukin-33 antibodies and uses thereof

Patent 11760797 was granted and assigned to Genentech on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 20 Sep, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 20 Sep, 2023
Edits made to:
Infobox (+42 properties)
Article (+230 characters)
‌

 US Patent 11760797 Anti-interleukin-33 antibodies and uses thereof

Article

Patent abstract

The invention provides interleukin-33 (IL-33) antibodies and methods of making and using the same, e.g., for treatment of IL-33 mediated disorders (e.g., ocular disorders such as AMD (e.g., geographic atrophy (GA)).

Infobox
Is a
Patent
Patent
Patent Applicant
Genentech
Genentech
Current Assignee
Genentech
Genentech
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11760797
Patent Inventor Names
Dhaya Seshasayee
Gerald R. Nakamura
Hiu Nam Chan
Hongkang Xi
Jack Bevers, III
Jia Wu
Laetitia Comps-Agrar
Menno Van Lookeren Campagne
Racquel Corpuz
Tiffany Wong
Date of Patent
September 19, 2023
Patent Application Number
17199810
Date Filed
March 12, 2021
Patent Citations
‌
US Patent 7172750 Compositions and methods for the treatment and diagnosis of immune disorders
‌
US Patent 7560530 IL-33 receptor
‌
US Patent 7674459 Treatment of cancer with a novel anti-IL13 monoclonal antibody
‌
US Patent 8067199 Anti-IL13 antibodies and uses thereof
‌
US Patent 8088618 Anti-IL 13 antibodies and uses thereof
‌
US Patent 8187569 Process for manufacturing molecular sieve of MFS framework type and its use
‌
US Patent 8187596 Method of treating asthma or allergy by administering an IL-33 receptor antibody
‌
US Patent 8318160 Treatment of cancer with novel anti-IL13 monoclonal antibodies
‌
US Patent 8734797 Anti-IL13 antibodies and uses thereof
‌
US Patent 9090694 ST2L antibody antagonists
‌
US Patent 9212227 ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
‌
US Patent 9309319 Antibodies against human IL33R and uses thereof
‌
US Patent 9453072 Anti-IL-33 antibodies
‌
US Patent 9523696 Methods for predicting risk of developing hypertension
‌
US Patent 9738727 Anti-HtrA1 antibodies and methods of use
‌
US Patent 9758578 Human anti-IL-33 neutralizing monoclonal antibody
‌
US Patent 9970944 Methods of modulating cytokine activity; related reagents
‌
US Patent 10000564 Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies
‌
US Patent 10059764 Antibodies directed against interleukin-33 (IL-33) and methods of making and using
‌
US Patent 10093730 Anti-interleukin-33 antibodies and uses thereof
‌
US Patent 10421822 Anti-HtrA1 antibodies and methods of use thereof
‌
US Patent 10723795 Anti-interleukin-33 antibodies and uses thereof
‌
US Patent 10836820 Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)
Patent Primary Examiner
‌
Marianne P Allen

Find more entities like US Patent 11760797 Anti-interleukin-33 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.